A Multicenter, Long-Term Extension Study to Assess Safety of Oral Sildenafil Citrate In The Treatment Of Subjects Who Have Completed Study A1481131
Latest Information Update: 02 Feb 2021
Price :
$35 *
At a glance
- Drugs Sildenafil (Primary)
- Indications Pulmonary arterial hypertension
- Focus Adverse reactions
- Acronyms STARTS-2
- Sponsors Pfizer
- 15 Oct 2013 New trial record